268 related articles for article (PubMed ID: 9042913)
1. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II.
De Paepe A; Nuytinck L; Hausser I; Anton-Lamprecht I; Naeyaert JM
Am J Hum Genet; 1997 Mar; 60(3):547-54. PubMed ID: 9042913
[TBL] [Abstract][Full Text] [Related]
2. A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I).
Wenstrup RJ; Langland GT; Willing MC; D'Souza VN; Cole WG
Hum Mol Genet; 1996 Nov; 5(11):1733-6. PubMed ID: 8923000
[TBL] [Abstract][Full Text] [Related]
3. The gene encoding collagen alpha1(V)(COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II.
Burrows NP; Nicholls AC; Yates JR; Gatward G; Sarathachandra P; Richards A; Pope FM
J Invest Dermatol; 1996 Jun; 106(6):1273-6. PubMed ID: 8752669
[TBL] [Abstract][Full Text] [Related]
4. A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families.
Burrows NP; Nicholls AC; Richards AJ; Luccarini C; Harrison JB; Yates JR; Pope FM
Am J Hum Genet; 1998 Aug; 63(2):390-8. PubMed ID: 9683580
[TBL] [Abstract][Full Text] [Related]
5. An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome.
Nicholls AC; Oliver JE; McCarron S; Harrison JB; Greenspan DS; Pope FM
J Med Genet; 1996 Nov; 33(11):940-6. PubMed ID: 8950675
[TBL] [Abstract][Full Text] [Related]
6. Identification of Two Independent
Bauer A; Bateman JF; Lamandé SR; Hanssen E; Kirejczyk SGM; Yee M; Ramiche A; Jagannathan V; Welle M; Leeb T; Bateman FL
Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31546637
[TBL] [Abstract][Full Text] [Related]
7. Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome.
Giunta C; Nuytinck L; Raghunath M; Hausser I; De Paepe A; Steinmann B
Am J Med Genet; 2002 May; 109(4):284-90. PubMed ID: 11992482
[TBL] [Abstract][Full Text] [Related]
8. A novel splice variant in the N-propeptide of COL5A1 causes an EDS phenotype with severe kyphoscoliosis and eye involvement.
Symoens S; Malfait F; Vlummens P; Hermanns-Lê T; Syx D; De Paepe A
PLoS One; 2011; 6(5):e20121. PubMed ID: 21611149
[TBL] [Abstract][Full Text] [Related]
9. Linkage of the gene that encodes the alpha 1 chain of type V collagen (COL5A1) to type II Ehlers-Danlos syndrome (EDS II).
Loughlin J; Irven C; Hardwick LJ; Butcher S; Walsh S; Wordsworth P; Sykes B
Hum Mol Genet; 1995 Sep; 4(9):1649-51. PubMed ID: 8541855
[TBL] [Abstract][Full Text] [Related]
10. COL5A1 exon 14 splice acceptor mutation causes a functional null allele, haploinsufficiency of alpha 1(V) and abnormal heterotypic interstitial fibrils in Ehlers-Danlos syndrome II.
Bouma P; Cabral WA; Cole WG; Marini JC
J Biol Chem; 2001 Apr; 276(16):13356-64. PubMed ID: 11278977
[TBL] [Abstract][Full Text] [Related]
11. The pro-alpha3(V) collagen chain. Complete primary structure, expression domains in adult and developing tissues, and comparison to the structures and expression domains of the other types V and XI procollagen chains.
Imamura Y; Scott IC; Greenspan DS
J Biol Chem; 2000 Mar; 275(12):8749-59. PubMed ID: 10722718
[TBL] [Abstract][Full Text] [Related]
12. A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito.
Toriello HV; Glover TW; Takahara K; Byers PH; Miller DE; Higgins JV; Greenspan DS
Nat Genet; 1996 Jul; 13(3):361-5. PubMed ID: 8673139
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro noncovalent association of excised alpha 1 (I) amino-terminal propeptides with mutant pN alpha 2(I) collagen chains in native mutant collagen in a case of Ehlers-Danlos syndrome, type VII.
Wirtz MK; Keene DR; Hori H; Glanville RW; Steinmann B; Rao VH; Hollister DW
J Biol Chem; 1990 Apr; 265(11):6312-7. PubMed ID: 2318855
[TBL] [Abstract][Full Text] [Related]
14. Genetic linkage to the collagen alpha 1 (V) gene (COL5A1) in two British Ehlers-Danlos syndrome families with variable type I and II phenotypes.
Burrows NP; Nicholls AC; Yates JR; Richards AJ; Pope FM
Clin Exp Dermatol; 1997 Jul; 22(4):174-6. PubMed ID: 9499606
[TBL] [Abstract][Full Text] [Related]
15. Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen.
Nuytinck L; Freund M; Lagae L; Pierard GE; Hermanns-Le T; De Paepe A
Am J Hum Genet; 2000 Apr; 66(4):1398-402. PubMed ID: 10739762
[TBL] [Abstract][Full Text] [Related]
16. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
[TBL] [Abstract][Full Text] [Related]
17. COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS.
Wenstrup RJ; Florer JB; Willing MC; Giunta C; Steinmann B; Young F; Susic M; Cole WG
Am J Hum Genet; 2000 Jun; 66(6):1766-76. PubMed ID: 10777716
[TBL] [Abstract][Full Text] [Related]
18. Compound heterozygosity for a disease-causing G1489E [corrected] and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability?
Giunta C; Steinmann B
Am J Med Genet; 2000 Jan; 90(1):72-9. PubMed ID: 10602121
[TBL] [Abstract][Full Text] [Related]
19. A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII.
Chiodo AA; Hockey A; Cole WG
J Biol Chem; 1992 Mar; 267(9):6361-9. PubMed ID: 1556139
[TBL] [Abstract][Full Text] [Related]
20. The Ehlers-Danlos syndromes.
Yeowell HN; Pinnell SR
Semin Dermatol; 1993 Sep; 12(3):229-40. PubMed ID: 8217561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
